Jeffrey Bailey

Mr. Jeffrey A. Bailey is an Independent Director at Aurinia Pharmaceuticals, Inc., an Independent Trustee at abrdn Healthcare Investors, an Independent Trustee at abrdn Healthcare Opportunities Fund, an Independent Trustee at abrdn Life Sciences Investors and an Independent Trustee at abrdn World Healthcare Fund.
He is on the Board of Directors at Aurinia Pharmaceuticals, Inc., Aberdeen Investments LLC, abrdn Healthcare Investors, abrdn Healthcare Opportunities Fund, abrdn Life Sciences Investors, abrdn World Healthcare Fund and Madison Vaccines, Inc. Mr. Bailey was previously employed as a Chief Executive Officer & Director by BioDelivery Sciences International, Inc., a Chairman by Tekla Capital Management LLC, a Chief Executive Officer & Director by IlluminOss Medical, Inc., a Chairman by Aileron Therapeutics, Inc., an Executive Chairman & Chief Executive Officer by Neurovance, Inc., an Independent Director by Landauer, Inc., a President, Chief Executive Officer & Director by Lantheus Holdings, Inc., a President, Chief Executive Officer & Director by BRISTOL-MYERS SQUIBB MEDICAL IMAGING, INC, a Chief Operating Officer by Fougera Pharmaceuticals, Inc., a Chief Commercial Officer by King Pharmaceuticals, Inc., a President & General Manager by Novartis AG, a President & GM-Northwest Operating Unit by Novartis Pharmaceuticals Corp., a Vice President-Sales by Johnson & Johnson, and a Vice President-Marketing by Mainevest LLC.
He also served on the board at Biodelivery Systems, Inc. and ImaginAb, Inc. He received his undergraduate degree from Rutgers State University of New Jersey.